Product Information
TELMISARTAN 80 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1563 per EA under NDC 68462020130. Its NADAC has been published 280 times since Apr 14, 2021.
FDA first approved this application on Jul 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462020130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA090032FDA Approved
7/7/2014
TE Code
AB
On Market Since
7/7/2014
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 80 MG TABLET has been published 280 times since Apr 14, 2021, and over the history we have for it it has declined 63.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1563 per EA |
|---|---|
| All-time high | $0.4303 (May 12, 2021) |
| All-time low | $0.1345 (May 22, 2024) |
| 52-week high | $0.1634 |
| 52-week low | $0.1473 |
| Median price | $0.2142 |
| Average price | $0.2351 |
| Largest weekly change | +53.7% (Nov 22, 2023) |
| Weeks tracked | 280 |
| Tracking since | Apr 14, 2021 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TELMISARTAN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 80 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1563 per EA (NDC 68462020130), effective Aug 19, 2026.
How has the price of TELMISARTAN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 80 MG TABLET has declined 63.3%. It has been tracked across 280 weekly CMS publications since Apr 14, 2021.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 80 MG TABLET?
Since Apr 14, 2021, the NADAC for TELMISARTAN 80 MG TABLET has ranged from a low of $0.1345 (May 22, 2024) to a high of $0.4303 (May 12, 2021), with a median of $0.2142 per EA.
Are there cheaper alternatives to TELMISARTAN 80 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 80 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TELMISARTAN 80 MG TABLET?
TELMISARTAN 80 MG TABLET (NDC 68462020130) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.